Enhancing wound healing and overcoming cisplatin resistance in ovarian cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Ovarian cancer (OC) presents significant challenges, including impaired wound healing and cisplatin (DDP) resistance.
• The role of microRNAs (miRNAs) in OC progression and treatment resistance is an area of active investigation.
• Understanding the molecular mechanisms underlying OC-associated wound healing deficits is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the role of miR-200b in ovarian cancer (OC).
• To elucidate the impact of miR-200b on wound healing processes via the DNMT3A/TGF-β1 pathway.
• To explore the regulation of autophagy by miR-200b and its effects on OC cisplatin resistance and wound healing.

Main Methods:

• Utilized DDP-sensitive (A2780) and resistant (A2780/DDP) OC cell lines and human fibroblast cultures.
• Employed cell transfection, chromatin immunoprecipitation (ChIP), dual-luciferase reporter (DLR) assays, quantitative PCR, Western blotting, MTT, and wound healing assays.
• Performed bioinformatics analysis to predict and validate molecular interactions.

Main Results:

• miR-200b inhibition in A2780 cells and mimic in A2780/DDP cells influenced cell viability, linking miR-200b to DDP resistance.
• A miR-200b mimic significantly delayed fibroblast-mediated wound closure, highlighting its role in wound healing.
• Confirmed miR-200b interaction with DNMT3A, affecting TGF-β1 expression, and validated these changes via ChIP, qPCR, and Western blot.

Conclusions:

• miR-200b plays a pivotal role in ovarian cancer (OC) by modulating autophagy.
• Autophagy regulation by miR-200b significantly impacts wound healing through the DNMT3A/TGF-β1 pathway in OC.
• miR-200b influences both wound healing and cisplatin resistance in ovarian cancer.